Mesenchymal Stem Cells in Clinical Trials for Immune Disorders

Zongjin Li; Zhibo Han; Zhong-Chao Han

doi:10.1055/s-0044-1788044

Mesenchymal Stem Cells in Clinical Trials for Immune Disorders

Glob Med Genet. 2024 Jun 27;11(3):196-199. doi: 10.1055/s-0044-1788044. eCollection 2024 Sep.

Authors

Zongjin Li¹, Zhibo Han^{2

3}, Zhong-Chao Han³

Affiliations

¹ Department of Pathophysiology, Nankai University School of Medicine, Tianjin, China.
² Academy of Medical Engineering and Translational Medicine, Tianjin University, Tianjin, China.
³ Beijing Engineering Laboratory of Perinatal Stem Cells, Beijing Institute of Health and Stem Cells, Health & Biotech Co., Beijing, China.

No abstract available

Publication types

Editorial

Grants and funding

Funding This work was supported by grants from the Tianjin Natural Science Foundation (21JCZDJC00070, 22JCZXJC00170) and the Nankai University Eye Institute (NKYKD202203).